Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Should PTSC inform shareholders of new Licencing Fee strategy?

But do we know what the the manor the Js are paying us? Does the company know? If so they have an advantage over us, don't they? Or am I not seeing the forest for the trees here?

Thanks, DW

2
Apr 22, 2008 10:33AM
Share
New Message
Please login to post a reply